Cannon Financial Strategists, Inc.
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 2031123
ATHENS, GA
Position in RYTM
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,110,300
+$240,600 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#158
of 299 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cannon Financial Strategists, Inc. holds $1,183,300 across 2 Biotechnology names. RYTM ranks #1 (93.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RYTM |
Rhythm Pharmaceuticals, Inc.
This page
|
10,000 | $1,110,300 | |
| 2 | TTRX |
Turn Therapeutics Inc.
|
10,000 | $73,000 |
All Filings in RYTM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,110,300 | 10,000 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $869,700 | 10,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,070,400 | 10,000 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,009,900 | 10,000 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $631,900 | 10,000 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $529,700 | 10,000 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $559,800 | 10,000 | Shares | Sole | 2025-02-03 | |
| No filing history on record for this holder in this stock. | ||||||